Wenli Qian

Wenli Qian

Auto-generated profile, based on publicly available information

Wenli Qian

Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry & Molecular Cellular Biology, Shanghai Jiaotong University School of Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
YZYihong Zhang
Yihong Zhang
XZXiuqun Zou
Xiuqun Zou
WQWenli Qian
Wenli Qian
XWXiaoling Weng
Xiaoling Weng
LZLin Zhang
Lin Zhang
ZHZhao-Yuan Hou
Zhao-Yuan Hou

24 September 2020 in Oncogene
Verified
Journal Article
Closed access
PDF file
WQWenli Qian
Wenli Qian
QLQi Li
Qi Li
XWXinglong Wu
Xinglong Wu
WLWenguo Li
Wenguo Li
QLQiwei Li
Qiwei Li
ZHZhao-Yuan Hou
Zhao-Yuan Hou

1 May 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MZMing-Na Zhao
Ming-Na Zhao
LZLing-Fei Zhang
Ling-Fei Zhang
ZSZhen Sun
Zhen Sun
LQLi-Hua Qiao
Li-Hua Qiao
TYTao Yang
Tao Yang
JLJiatao Lou
Jiatao Lou
Bone metastasis is one of the main complications of lung cancer and most important factors that lead to poor life quality and low survival rate in lung cancer patients. However, the regulatory mechanisms underlying lung cancer bone metastasis are still poor understood. Here, we report that microRNA-182 (miR-182) plays a critical role in regulating osteoclastic metastasis of lung cancer cells. We found that miR-182 was significantly upregulated in both bone-metastatic human non–small cell lung cancer (NSCLC) cell line and tumor specimens. We further demonstrated that miR-182 markedly enhanced the ability of NSCLC cells for osteolytic bone metastasis in nude mice. Mechanistically, miR-182 promotes NSCLC cells to secrete Interleukin-8 (IL-8) and in turn facilitates osteoclastogenesis via activating STAT3 signaling in osteoclast progenitor cells. Importantly, systemically delivered IL-8 neutralizing antibody inhibits NSCLC bone metastasis in nude mice. Collectively, our findings identify the miR-182/IL-8/STAT3 axis as a key regulatory pathway in controlling lung cancer cell-induced osteolytic bone metastasis and suggest a promising therapeutic strategy that targets this regulatory axis to interrupt lung cancer bone metastasis.

3 May 2026 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
HZHui Zhang
Hui Zhang
WQWenli Qian
Wenli Qian
MLMengying Li
Mengying Li
XZXiuqun Zou
Xiuqun Zou
XCXiaolin Chen
Xiaolin Chen
ZHZhao-Yuan Hou
Zhao-Yuan Hou
Endoplasmic reticulum associated degradation (ERAD) plays pivotal role in protein homeostasis and quality control in normal and cancer cells, yet the regulatory mechanism of ERAD remains elusive, especially regarding its ubiquitination function mediated by hydroxymethylglutaryl reductase degradation protein 1 (HRD1). Here, we report that Sel-1 Suppressor of Lin-12-Like 3 (SEL1L3) protein resided on the ER membrane can effectively prevent HRD1-mediated ERAD process via dual mechanisms: SEL1L3 disrupts SEL1L-HRD1 complex by mutually exclusively interacting with SEL1L and HRD1 respectively, resulting in concomitant prevention of substrate degradation; on the other hand, SEL1L3 can accelerate HRD1 protein degradation. Biologically, SEL1L3 inhibits colorectal cancer (CRC) cell growth and migration, which counteracts the oncogenic activity of HRD1; moreover, we identify STING as a HRD1 substrate and a critical downstream effector mediating tumor suppression activity of SEL1L3. Collectively, these data demonstrate that SEL1L3 is a critical regulator of ERAD and exerts a potent tumor-suppressing function, and that the SEL1L3/HRD1/STING axis plays a crucial role in CRC growth and migration.